GULDSMED CLAUSEN IVS: Financial statements 2017
CVR: 35857540
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GULDSMED CLAUSEN IVS (CVR 35857540) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 28,895 and a net result of DKK 3,991 compared with DKK 1,173 the year before. That is a decrease of 24.2% compared with the year before. The profit margin was 13.8%. Equity in the 2017 report amounted to DKK 750. The solvency ratio was 12.1%.
- Revenue
- DKK 28,895
- Gross Profit
- DKK 5,587
- Profit/Loss
- DKK 3,991
- Equity
- DKK 750
- Total Assets
- DKK 6,188
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 29K | 6K | 4K | 750 | - |
| 2016 | 38K | 8K | 1K | -3K | - |
| 2015 | 34K | 7K | 7K | -4K | - |
Official annual report
Keep an eye on GULDSMED CLAUSEN IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
GULDSMED CLAUSEN IVS has published its annual report for 2016. Revenue came to DKK 38,138, and the net result was DKK 1,173.
About GULDSMED CLAUSEN IVS
GULDSMED CLAUSEN IVS was a Danish company of the type Iværksætterselskab based in Aabenraa, founded in 2014. The company has been dissolved on 19 June 2020. The company was registered under the industry Uoplyst. In 2019, the company reported a gross profit of DKK -1,684 and a net result of DKK -1,684 compared with DKK 1,067 the year before. Equity in the 2019 report amounted to DKK 133.
